National Health Act (Pharmaceutical Benefits – Early Supply) Amendment April 2010 - specification under subsection 84AAA(2) (No. PB 28 of 2010)

Link to law: https://www.comlaw.gov.au/Details/F2010L00755

 
COMMONWEALTH OF AUSTRALIA
Instrument number PB 28 of 2010
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment April 2010 - Specification Under Subsection 84AAA(2)
 
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
 
I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
 
Dated                    24      March 2010
 
 
FELICITY MCNEILL
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
 
 
 
Amendment determination — Pharmaceutical Benefits - Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment April 2010 - specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as “No. PB 28 of 2010”.
 
2          Commencement
 
This Instrument commences on 1 April 2010.
 
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.
 
Schedule 1        Amendments
[1]                                  Schedule 1, after item dealing with Lansoprazole, Capsule 15 mg
insert in the columns in the order indicated:
 
 
Capsule 30 mg
Oral
28
5
 

Tablet 15 mg (orally disintegrating)
Oral
28
5
 

 
[2]                                  Schedule 1, item dealing with Lercanidipine, Tablet containing lercanidipine hydrochloride 10 mg
omit from the column “Maximum quantity or number of units”:
          30
and substitute:
          28
 
[3]                                  Schedule 1, item dealing with Lercanidipine, Tablet containing lercanidipine hydrochloride 20 mg
omit from the column “Maximum quantity or number of units”:
          30
and substitute:
          28
 
[4]                                  Schedule 1, item dealing with Lercanidipine with enalapril, Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg
omit from the column “Maximum quantity or number of units”:
          30
and substitute:
          28
[5]                                  Schedule 1, item dealing with Lercanidipine with enalapril, Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg
omit from the column “Maximum quantity or number of units”:
          30
and substitute:
          28
 
Read Entire Law on www.comlaw.gov.au